About
About HNDC
Services
About Huntington Disease
Our Staff
Newsletters
Testimonials
Events
Donate
Research
News
Contact Us

Hereditary Neurological Disease Centre

About
About HNDC
Services
About Huntington Disease
Our Staff
Newsletters
Testimonials
Events
Donate
Research
News
Contact Us
Danielle Lehman
September 16, 2018

Update on RG6042 (formerly known as IONIS-HTTRx) Huntington’s disease global development programme: Two clinical studies to begin by end of 2018

Danielle Lehman
September 16, 2018

Click here to read the letter from Genentech, a member of the Roche group.

Newer PostHNDC Selected to Participate in Phase 3 Trial of Valbenazine
Older Post‘I feel so much hope’—Is a new drug keeping this woman’s deadly Huntington disease at bay?

Contact us today to schedule a consultation.

Get in touch →
Back to Top
CHDI Foundation
Enroll-HD
Huntington Study Group
 
 

© Copyright 2016 Hereditary Neurological Disease Centre